3649.T
FINDEX Inc. [3649.T] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
3649.T Stock Summary
Top 10 Correlated ETFs
3649.T
Top 10 Correlated Stocks
3649.T
In the News
3649.T Financial details
Company Rating
Strong Buy
Market Cap
28.31B
Income
1.06B
Revenue
5.19B
Book val./share
188.67
Cash/share
105.01
Dividend
11
Dividend %
1.12%
Employees
290
Optionable
No
Shortable
Yes
Earnings
14 May 2024
P/E
26.79
Forward P/E
-
PEG
5.77
P/S
5.24
P/B
5.79
P/C
9.59
P/FCF
-
Quick Ratio
8.67
Current Ratio
9.59
Debt / Equity
0.07
LT Debt / Equity
-0
-
-
EPS (TTM)
41.3
EPS next Y
-
EPS next Q
-
EPS this Y
46.44%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
16.2%
Revenue last 5Y
3.93%
Revenue Q/Q
40.18%
EPS Q/Q
73.57%
-
-
-
-
SMA20
-9.89%
SMA50
2.07%
SMA100
18.46%
Inst Own
-
Inst Trans
-
ROA
19%
ROE
23%
ROC
0.29%
Gross Margin
62%
Oper. Margin
27%
Profit Margin
19%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
568.0-1289.0
52W High
-21.88%
52W Low
+77.29%
RSI
37.75
Rel Volume
1.01
Avg Volume
97.85K
Volume
98.5K
Perf Week
-10.57%
Perf Month
-19.44%
Perf Quarter
14.43%
Perf Half Y
11.64%
-
-
-
-
Beta
0.73
-
-
Volatility
33.26%, 69.62%
Prev Close
-1.66%
Price
1007
Change
-1.27%
3649.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 167.25 | 156.41 | 194.03 | 177.27 | 202.51 | |
| Net income per share | 19.5 | 16.81 | 24.84 | 28.21 | 41.31 | |
| Operating cash flow per share | 65.24 | 21.19 | 29.3 | 27.08 | 32.88 | |
| Free cash flow per share | 50.72 | 10.98 | 18.78 | 14.85 | 21.84 | |
| Cash per share | 79.53 | 87.11 | 89.73 | 99.14 | 105.05 | |
| Book value per share | 111.04 | 120.03 | 137.05 | 157.65 | 188.74 | |
| Tangible book value per share | 96.03 | 109.02 | 127.83 | 148.01 | 177.67 | |
| Share holders equity per share | 111.04 | 120.03 | 137.05 | 157.65 | 188.74 | |
| Interest debt per share | 0 | 0 | 0.78 | -4.07 | 12.92 | |
| Market cap | 34.66B | 29.73B | 25.76B | 12.66B | 26.41B | |
| Enterprise value | 32.75B | 27.63B | 23.61B | 10.24B | 23.84B | |
| P/E ratio | 69.43 | 69.06 | 40.5 | 17.51 | 24.93 | |
| Price to sales ratio | 8.1 | 7.42 | 5.18 | 2.79 | 5.09 | |
| POCF ratio | 20.76 | 54.79 | 34.33 | 18.24 | 31.33 | |
| PFCF ratio | 26.69 | 105.73 | 53.55 | 33.26 | 47.17 | |
| P/B Ratio | 12.19 | 9.67 | 7.34 | 3.13 | 5.46 | |
| PTB ratio | 12.19 | 9.67 | 7.34 | 3.13 | 5.46 | |
| EV to sales | 7.65 | 6.9 | 4.75 | 2.26 | 4.59 | |
| Enterprise value over EBITDA | 27.96 | 27.18 | 18.85 | 7.81 | 13.59 | |
| EV to operating cash flow | 19.61 | 50.92 | 31.47 | 14.76 | 28.29 | |
| EV to free cash flow | 25.22 | 98.25 | 49.08 | 26.92 | 42.59 | |
| Earnings yield | 0.01 | 0.01 | 0.02 | 0.06 | 0.04 | |
| Free cash flow yield | 0.04 | 0.01 | 0.02 | 0.03 | 0.02 | |
| Debt to equity | 0 | 0 | 0.01 | -0.03 | 0.07 | |
| Debt to assets | 0 | 0 | 0 | -0.02 | 0.06 | |
| Net debt to EBITDA | -1.63 | -2.07 | -1.72 | -1.84 | -1.46 | |
| Current ratio | 5.4 | 5.9 | 4.49 | 6.31 | 6.48 | |
| Interest coverage | 0 | 0 | 460.36K | 2.3K | 0 | |
| Income quality | 2.24 | 0.84 | 0.79 | 0.65 | 0.8 | |
| Dividend Yield | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | |
| Payout ratio | 0.41 | 0.48 | 0.32 | 0.32 | 0.26 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.11 | 0.07 | 0.05 | 0.05 | 0.05 | |
| Capex to operating cash flow | -0.22 | -0.48 | -0.36 | -0.45 | -0.34 | |
| Capex to revenue | -0.09 | -0.07 | -0.05 | -0.07 | -0.05 | |
| Capex to depreciation | -0.87 | -0.69 | -0.87 | -1.23 | -1.1 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 220.74 | 213.08 | 276.75 | 316.36 | 418.86 | |
| ROIC | 0.18 | 0.14 | 0.18 | 0.18 | 0.2 | |
| Return on tangible assets | 0.16 | 0.12 | 0.15 | 0.15 | 0.19 | |
| Graham Net | 73.78 | 85.64 | 90.19 | 108.55 | 125.42 | |
| Working capital | 2.14B | 2.62B | 2.88B | 3.47B | 4.23B | |
| Tangible asset value | 2.46B | 2.79B | 3.27B | 3.79B | 4.55B | |
| Net current asset value | 2.01B | 2.43B | 2.66B | 3.19B | 3.92B | |
| Invested capital | 0 | 0 | 0.01 | -0.03 | 0.07 | |
| Average receivables | 929.15M | 625.93M | 962.83M | 1.29B | 1.64B | |
| Average payables | 43.19M | 29.51M | 124.13M | 152.42M | 60.29M | |
| Average inventory | 99.37M | 222.24M | 297.6M | 299.67M | 327.6M | |
| Days sales outstanding | 46.46 | 64.42 | 89.53 | 109.41 | 135.27 | |
| Days payables outstanding | 6.43 | 4.77 | 33.84 | 16.3 | 7.72 | |
| Days of inventory on hand | 24.81 | 60.38 | 42.87 | 63.43 | 66.48 | |
| Receivables turnover | 7.86 | 5.67 | 4.08 | 3.34 | 2.7 | |
| Payables turnover | 56.74 | 76.52 | 10.79 | 22.39 | 47.29 | |
| Inventory turnover | 14.71 | 6.04 | 8.51 | 5.75 | 5.49 | |
| ROE | 0.18 | 0.14 | 0.18 | 0.18 | 0.22 | |
| Capex per share | -14.51 | -10.21 | -10.52 | -12.23 | -11.04 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 60.17 | 48.86 | 38.9 | 47.77 | 66.96 | |
| Net income per share | 14.56 | 7.78 | 3.29 | 11.05 | 19.18 | |
| Operating cash flow per share | 4.89 | 4.85 | 4.94 | 5 | 5.41 | |
| Free cash flow per share | 4.89 | 4.85 | 4.94 | 5 | 5.41 | |
| Cash per share | 99.13 | 96.39 | 119.63 | 105.41 | 105.01 | |
| Book value per share | 157.63 | 158.92 | 162.61 | 169.7 | 188.67 | |
| Tangible book value per share | 147.99 | 149.41 | 152.92 | 159.35 | 177.61 | |
| Share holders equity per share | 157.63 | 158.92 | 162.61 | 169.7 | 188.67 | |
| Interest debt per share | -3.95 | 0.02 | 0 | 0 | 12.92 | |
| Market cap | 12.66B | 17.63B | 16.57B | 19.31B | 26.42B | |
| Enterprise value | 10.24B | 15.16B | 13.62B | 16.61B | 23.85B | |
| P/E ratio | 8.48 | 22.1 | 49.04 | 17.04 | 13.42 | |
| Price to sales ratio | 8.21 | 14.08 | 16.61 | 15.76 | 15.38 | |
| POCF ratio | 100.98 | 141.83 | 130.71 | 150.65 | 190.33 | |
| PFCF ratio | 100.98 | 141.83 | 130.71 | 150.65 | 190.33 | |
| P/B Ratio | 3.13 | 4.33 | 3.97 | 4.44 | 5.46 | |
| PTB ratio | 3.13 | 4.33 | 3.97 | 4.44 | 5.46 | |
| EV to sales | 6.64 | 12.11 | 13.66 | 13.56 | 13.89 | |
| Enterprise value over EBITDA | 19.07 | 51.88 | 114.34 | 40.94 | 31.05 | |
| EV to operating cash flow | 81.73 | 121.96 | 107.5 | 129.56 | 171.86 | |
| EV to free cash flow | 81.73 | 121.96 | 107.5 | 129.56 | 171.86 | |
| Earnings yield | 0.03 | 0.01 | 0.01 | 0.01 | 0.02 | |
| Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Debt to equity | -0.03 | 0 | 0 | 0 | 0.07 | |
| Debt to assets | -0.02 | 0 | 0 | 0 | 0.06 | |
| Net debt to EBITDA | -4.49 | -8.45 | -24.69 | -6.66 | -3.34 | |
| Current ratio | 6.31 | 7.16 | 8.59 | 9.59 | 6.48 | |
| Interest coverage | 155.81 | 461.32 | 0 | 0 | 0 | |
| Income quality | 0.34 | 0.62 | 1.51 | 0.45 | 0.28 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 227.24 | 166.83 | 109.77 | 205.38 | 285.36 | |
| ROIC | 0.1 | 0.05 | 0.02 | 0.06 | 0.09 | |
| Return on tangible assets | 0.08 | 0.04 | 0.02 | 0.06 | 0.09 | |
| Graham Net | 108.54 | 106.63 | 118.67 | 116.53 | 125.38 | |
| Working capital | 3.47B | 3.52B | 3.59B | 3.77B | 4.23B | |
| Tangible asset value | 3.79B | 3.83B | 3.92B | 4.09B | 4.55B | |
| Net current asset value | 3.19B | 3.24B | 3.31B | 3.49B | 3.92B | |
| Invested capital | -0.03 | 0 | 0 | 0 | 0.07 | |
| Average receivables | 969.13M | 1.31B | 1.01B | 929.07M | 1.51B | |
| Average payables | 66.18M | 83.47M | 52.19M | 26.05M | 36.42M | |
| Average inventory | 326.65M | 327.58M | 326.29M | 331.8M | 344.69M | |
| Days sales outstanding | 79.47 | 90.67 | 68.19 | 80.98 | 100.83 | |
| Days payables outstanding | 12.82 | 14.37 | 3.88 | 8.07 | 6.81 | |
| Days of inventory on hand | 49.88 | 56.84 | 65.32 | 84.48 | 58.67 | |
| Receivables turnover | 1.13 | 0.99 | 1.32 | 1.11 | 0.89 | |
| Payables turnover | 7.02 | 6.26 | 23.17 | 11.15 | 13.21 | |
| Inventory turnover | 1.8 | 1.58 | 1.38 | 1.07 | 1.53 | |
| ROE | 0.09 | 0.05 | 0.02 | 0.07 | 0.1 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
3649.T Frequently Asked Questions
What is FINDEX Inc. stock symbol ?
FINDEX Inc. is a JP stock and trading under the symbol 3649.T
What is FINDEX Inc. stock quote today ?
FINDEX Inc. stock price is $1007 today.
Is FINDEX Inc. stock public?
Yes, FINDEX Inc. is a publicly traded company.
Company Profile
- Volume Average 97.85K
- Market Capitalization 28.31B
- Employee 290
- CEO Mr. Teruo Aibara
- Headquarters Tokyo,JP
- IPO Date 2011-03-23
-
Website
https://www.findex.co.jp 
FINDEX Inc. engages in the research and development, manufacture, and sale of medical systems in Japan. The company's products include Claio, a medical imaging database management system for small, medium, and large size hospitals; and C-Note, a progress note system. It also offers DocuMaker, a document and data management system, which provides various input tools to enhance productivity in document creation; and GAP/GAP-screener, a gaze analyzing perimeter. In addition, the company develops applications for smart phone. It serves medical institutions, hospitals, and clinics. The company was formerly known as PSC Inc. and changed its name to FINDEX Inc. in November 2014. FINDEX Inc. was founded in 1985 and is headquartered in Tokyo, Japan.
